Regeneron Pharmaceuticals Dividends
| REGN Stock | USD 801.01 11.26 1.39% |
As of the 9th of January 2026, Dividend Paid And Capex Coverage Ratio is likely to grow to 5.53, while Dividends Paid is likely to drop about 233.9 M. Regeneron Pharmaceuticals' past performance could be the main factor of why investors trade Regeneron Pharmaceuticals stock today. Investors should clearly understand every aspect of the Regeneron Pharmaceuticals dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Regeneron Pharmaceuticals' dividend schedule and payout information. Regeneron Pharmaceuticals dividends can also provide a clue to the current valuation of Regeneron Pharmaceuticals.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 412.5 M | 233.9 M | |
| Dividend Paid And Capex Coverage Ratio | 5.26 | 5.53 |
Regeneron | Build AI portfolio with Regeneron Stock |
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Regeneron Pharmaceuticals must own a stock before its ex-dividend date to receive its next dividend.
Regeneron Pharmaceuticals Dividends Paid Over Time
Today, most investors in Regeneron Pharmaceuticals Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Regeneron Pharmaceuticals' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's dividends paid growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Regeneron Pharmaceuticals dividends paid as a starting point in their analysis.
The total amount of dividends that a company has paid out to its shareholders over a specific period. Dividends Paid |
| Timeline |
Recent Regeneron Pharmaceuticals Dividends Paid (per share)
Dividends Paid |
| Timeline |
Regeneron Pharmaceuticals Expected Dividend Income Per Share
Dividend payment represents part of Regeneron Pharmaceuticals' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Regeneron Pharmaceuticals. Regeneron Pharmaceuticals' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$1.47 |
One Year
Regeneron Pharmaceuticals expected dividend income per share adjusted for ongoing price standard deviation
Regeneron Pharmaceuticals Past Distributions to stockholders
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regeneron Pharmaceuticals. If investors know Regeneron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regeneron Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 2.64 | Earnings Share 41.75 | Revenue Per Share | Quarterly Revenue Growth 0.009 |
The market value of Regeneron Pharmaceuticals is measured differently than its book value, which is the value of Regeneron that is recorded on the company's balance sheet. Investors also form their own opinion of Regeneron Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Regeneron Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regeneron Pharmaceuticals' market value can be influenced by many factors that don't directly affect Regeneron Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regeneron Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Regeneron Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regeneron Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.